PerkinElmer's Q1 Revenues Climb 14 Percent on Human Health Segment Strength | GenomeWeb

NEW YORK (GenomeWeb News) – PerkinElmer's first-quarter revenues rose 14 percent year over year with particular strength in its Human Health segment, the company reported after the close of the market on Thursday.

For the three months ended April 1, total revenues were $510.9 million, up from $447.2 million a year ago, and nudging past analyst estimates of $510.4 million. Organically, revenues increased 6 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.

The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.

In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.